{"cursor":"9910","size":15,"audio":[],"currentlang":"en","article":"{{Infobox company\n| company_name = Alexion Pharmaceuticals company_logo = company_type = Public\n| traded_as = |NASDAQ-100 component}} S&P 500 Component foundation = 1992 founder = location_city = Cheshire,\n| Connecticut, U.S. key_people = Max E. Link\n| (Chairman) Leonard Bell (CEO) industry =\n| Pharmaceutical products = Eculizumab revenue = US$ 1134.114 million\n| (2012) 45% operating_income = US$\n| 404.338 mil (2012)75% net_income = US$\n| 254.822 mil (2012)45% assets = US$\n| 2.61356 bil (2012)87% equity = US$\n| 1.97085 bil (2012)74% num_employees =\n| 1500 (December 2012) homepage =\n| [http://www.alxn.com/ alxn.com]\n}}\n\n'Alexion Pharmaceuticals' is the original developer and distributor of Soliris,\na drug used in treating the rare disorders Hemolytic-uremic syndrome (HUS) and\nParoxysmal nocturnal hemoglobinuria (PNH).\n\nThe company is also involved in research regarding the immune system and how it\ncan be stopped from attacking healthy tissue (done by inhibiting terminal\ncomplements).\n\nSoliris, the company's sole marketed drug, has been approved for use in the EU\nand Japan however its availability in other places like the USA and Canada is\nlimited due to marketing restrictions and lack of ensured access (in Canada\naccess to the drug is mostly through private clinics though groups like the\nCanadian Association of PNH Patients are lobbying to change that).\n\nIn 2012 37% of sales originated in the US down from 43%, with 35% coming from\nEurope up from 34%. In 2011 50% of the increase in assets\ncame from cash and cash equivalents, the value of which has since gone down\nsince part of it was spent on acquiring Enobia. In the last quarter R&D spending\nwas higher due to expansion of development programs while net sales of Soliris\nincreased 45% to $227.6 million on account of new international patients with\nparoxysmal nocturnal hemoglobinuria.\n","linknr":308,"url":"Alexion_Pharmaceuticals","recorded":1376425786,"links":["/w/index.php?title=Alexion_Pharmaceuticals&action=edit","/w/index.php?title=Alexion_Pharmaceuticals&action=edit","//bits.wikimedia.org/favicon/wikipedia.ico","/w/opensearch_desc.php","//en.wikipedia.org/w/api.php?action=rsd","//creativecommons.org/licenses/by-sa/3.0/","/w/index.php?title=Special:RecentChanges&feed=atom","http://en.wikipedia.org/wiki/Alexion_Pharmaceuticals","//bits.wikimedia.org/en.wikipedia.org/load.php?debug=false&lang=en&modules=ext.gadget.DRN-wizard%2CReferenceTooltips%2Ccharinsert%2Cteahouse%7Cext.rtlcite%2Cwikihiero%7Cext.uls.nojs%7Cmediawiki.legacy.commonPrint%2Cshared%7Cmw.PopUpMediaTransform%7Cskins.vector&only=styles&skin=vector&*","//bits.wikimedia.org/en.wikipedia.org/load.php?debug=false&lang=en&modules=ext.visualEditor.viewPageTarget.noscript&only=styles&skin=vector&*","//bits.wikimedia.org/en.wikipedia.org/load.php?debug=false&lang=en&modules=site&only=styles&skin=vector&*","//bits.wikimedia.org/en.wikipedia.org/load.php?debug=false&lang=en&modules=startup&only=scripts&skin=vector&*","//bits.wikimedia.org/geoiplookup","//meta.wikimedia.org","#mw-navigation","#p-search","/wiki/File:Alexion_Pharmaceuticals_logo.svg","//upload.wikimedia.org/wikipedia/en/thumb/9/9e/Alexion_Pharmaceuticals_logo.svg/275px-Alexion_Pharmaceuticals_logo.svg.png","/wiki/Types_of_business_entity","/wiki/Public_company","/wiki/Ticker_symbol","/wiki/NASDAQ","http://www.nasdaq.com/symbol/alxn","/wiki/NASDAQ-100","/wiki/S%26P_500","/wiki/Pharmaceutical_industry","/wiki/Cheshire,_Connecticut","/wiki/Connecticut","/wiki/United_States","/wiki/Chairman","/wiki/Chief_Executive_Officer","/wiki/Eculizumab","/wiki/United_States_Dollar","//upload.wikimedia.org/wikipedia/commons/thumb/b/b0/Increase2.svg/11px-Increase2.svg.png","#cite_note-2012report-1","/wiki/Earnings_before_interest_and_taxes","//upload.wikimedia.org/wikipedia/commons/thumb/b/b0/Increase2.svg/11px-Increase2.svg.png","#cite_note-2012report-1","/wiki/Net_income","//upload.wikimedia.org/wikipedia/commons/thumb/b/b0/Increase2.svg/11px-Increase2.svg.png","#cite_note-2012report-1","/wiki/Asset","//upload.wikimedia.org/wikipedia/commons/thumb/b/b0/Increase2.svg/11px-Increase2.svg.png","#cite_note-2012report-1","/wiki/Equity_(finance)","//upload.wikimedia.org/wikipedia/commons/thumb/b/b0/Increase2.svg/11px-Increase2.svg.png","#cite_note-2012report-1","#cite_note-2012report-1","http://www.alxn.com/","/wiki/Eculizumab","/wiki/Hemolytic-uremic_syndrome","/wiki/Paroxysmal_nocturnal_hemoglobinuria","#cite_note-2","#cite_note-3","/wiki/Complement_membrane_attack_complex","/wiki/EU","#cite_note-4","#cite_note-2012report-1","#cite_note-4Q-5","#History","#Alexion_donates_Soliris_to_German_E_coli_patients","#Soliris_receives_FDA_approval","#Alexion_accused_of_.22moral_blackmail.22_in_Belgium","#References","#External_links","/w/index.php?title=Alexion_Pharmaceuticals&action=edit&section=1","/w/index.php?title=Alexion_Pharmaceuticals&veaction=edit&section=1","#cite_note-6","#cite_note-7","/wiki/Cheshire,_Connecticut","/wiki/Genzyme","#cite_note-8","/wiki/Duke_University","#cite_note-9","#cite_note-10","/wiki/Hypophosphatasia","/w/index.php?title=Alexion_Pharmaceuticals&action=edit&section=2","/w/index.php?title=Alexion_Pharmaceuticals&veaction=edit&section=2","/wiki/Shiga_toxin","/wiki/Hemolytic-uremic_syndrome","#cite_note-11","/w/index.php?title=Alexion_Pharmaceuticals&action=edit&section=3","/w/index.php?title=Alexion_Pharmaceuticals&veaction=edit&section=3","/wiki/Food_and_Drug_Administration","/wiki/Hemolytic-uremic_syndrome#Atypical_cases","#cite_note-12","/w/index.php?title=Alexion_Pharmaceuticals&action=edit&section=4","/w/index.php?title=Alexion_Pharmaceuticals&veaction=edit&section=4","#cite_note-13","#cite_note-14","#cite_note-15","#cite_note-16","#cite_note-17","#cite_note-18","/w/index.php?title=Alexion_Pharmaceuticals&action=edit&section=5","/w/index.php?title=Alexion_Pharmaceuticals&veaction=edit&section=5","#cite_ref-2012report_1-0","#cite_ref-2012report_1-1","#cite_ref-2012report_1-2","#cite_ref-2012report_1-3","#cite_ref-2012report_1-4","#cite_ref-2012report_1-5","#cite_ref-2012report_1-6","http://ir.alexionpharm.com/common/download/download.cfm?companyid=ALXN&fileid=653720&filekey=54B6E214-6EAC-49F1-A94B-10BC0EC8B119&filename=2012_Annual_Report.pdf","#cite_ref-2","http://www.medicalnewstoday.com/articles/221849.php","#cite_ref-3","http://www.forbes.com/companies/alexion-pharmaceuticals/","#cite_ref-4","http://www.zacks.com/stock/news/50969/Alexion+Seeks+Label+Expansion","#cite_ref-4Q_5-0","http://www.alxn.com/News/article.aspx?relid=647490","#cite_ref-6","http://ir.alexionpharm.com/secfiling.cfm?filingID=1005477-00-8099","#cite_ref-7","http://ir.alexionpharm.com/secfiling.cfm?filingID=1005477-00-8099","#cite_ref-8","http://ir.nasdaqomx.com/releasedetail.cfm?ReleaseID=560664","#cite_ref-9","http://www.medpagetoday.com/Cardiology/PCI/4638","#cite_ref-10","http://www.businessweek.com/news/2011-12-29/alexion-to-pay-as-much-as-1-08-billion-to-buy-enobia-pharma.html","#cite_ref-11","http://www.hartfordbusiness.com/news18747.html","#cite_ref-12","http://www.businesswire.com/news/home/20110923005612/en/Soliris%C2%AE-eculizumab-Approved-FDA-Patients-Atypical-Hemolytic","#cite_ref-13","http://deredactie.be/cm/vrtnieuws/binnenland/1.1617223","#cite_ref-14","http://deredactie.be/cm/vrtnieuws/binnenland/130502_terzake_debat_geneesmiddelen","#cite_ref-15","http://www.standaard.be/cnt/DMF20130504_00566977","#cite_ref-16","http://deredactie.be/cm/vrtnieuws/binnenland/130504_Alexion_Viktor","#cite_ref-17","http://www.standaard.be/cnt/DMF20130506_00568721","#cite_ref-18","http://www.standaard.be/cnt/DMF20130507_00570744","/w/index.php?title=Alexion_Pharmaceuticals&action=edit&section=6","/w/index.php?title=Alexion_Pharmaceuticals&veaction=edit&section=6","http://www.alxn.com","/wiki/Template:NASDAQ-100","/wiki/Template_talk:NASDAQ-100","//en.wikipedia.org/w/index.php?title=Template:NASDAQ-100&action=edit","/wiki/United_States","//upload.wikimedia.org/wikipedia/en/thumb/a/a4/Flag_of_the_United_States.svg/23px-Flag_of_the_United_States.svg.png","/wiki/NASDAQ-100","/wiki/Activision_Blizzard","/wiki/Adobe_Systems","/wiki/Akamai_Technologies","/wiki/Altera","/wiki/Amazon.com","/wiki/Amgen","/wiki/Analog_Devices","/wiki/Apple_Inc.","/wiki/Applied_Materials","/wiki/Autodesk","/wiki/Automatic_Data_Processing","/wiki/Avago_Technologies","/wiki/Baidu","/wiki/Bed_Bath_%26_Beyond","/wiki/Biogen_Idec","/wiki/BMC_Software","/wiki/Broadcom","/wiki/Catamaran_Corporation","/wiki/C._H._Robinson_Worldwide","/wiki/CA_Technologies","/wiki/Celgene","/wiki/Cerner","/wiki/Check_Point","/wiki/Cisco_Systems","/wiki/Citrix_Systems","/wiki/Cognizant","/wiki/Comcast","/wiki/Costco","/wiki/Dell","/wiki/Dentsply","/wiki/DirecTV","/wiki/Discovery_Communications","/wiki/Dollar_Tree","/wiki/EBay","/wiki/Equinix","/wiki/Expedia,_Inc.","/wiki/Expeditors_International","/wiki/Express_Scripts","/wiki/F5_Networks","/wiki/Facebook,_Inc.","/wiki/Fastenal","/wiki/Fiserv","/wiki/Fossil,_Inc.","/wiki/Garmin","/wiki/Gilead_Sciences","/wiki/Google","/wiki/Henry_Schein","/wiki/Intel","/wiki/Intuit","/wiki/Intuitive_Surgical","/wiki/KLA_Tencor","/wiki/Kraft_Foods","/wiki/Liberty_Global","/wiki/Liberty_Interactive","/wiki/Liberty_Media","/wiki/Life_Technologies","/wiki/Linear_Technology","/wiki/Mattel","/wiki/Maxim_Integrated","/wiki/Microchip_Technology","/wiki/Micron_Technology","/wiki/Microsoft","/wiki/Mondel%C4%93z_International","/wiki/Monster_Beverage","/wiki/Mylan","/wiki/NetApp","/wiki/Netflix","/wiki/News_Corporation","/wiki/Nuance_Communications","/wiki/Nvidia","/wiki/O%27Reilly_Auto_Parts","/wiki/Paccar","/wiki/Paychex","/wiki/Priceline.com","/wiki/Qualcomm","/wiki/Randgold_Resources","/wiki/Regeneron","/wiki/Ross_Stores","/wiki/SanDisk","/wiki/SBA_Communications","/wiki/Seagate_Technology","/wiki/Sears_Holdings","/wiki/Sigma-Aldrich","/wiki/Sirius_XM_Radio","/wiki/Staples_Inc.","/wiki/Starbucks","/wiki/Stericycle","/wiki/Symantec","/wiki/Tesla_Motors","/wiki/Texas_Instruments","/wiki/Verisk_Analytics","/wiki/Vertex_Pharmaceuticals","/wiki/Viacom","/wiki/Vodafone","/wiki/Western_Digital","/wiki/Whole_Foods_Market","/wiki/Wynn_Resorts","/wiki/Xilinx","/wiki/Yahoo!","//en.wikipedia.org/w/index.php?title=Special:CentralAutoLogin/start&type=1x1&from=enwiki","http://en.wikipedia.org/w/index.php?title=Alexion_Pharmaceuticals&oldid=567523539","/wiki/Help:Category","/wiki/Category:Companies_in_the_NASDAQ-100_Index","/wiki/Category:Pharmaceutical_companies_of_the_United_States","/wiki/Category:Companies_based_in_Connecticut","/wiki/Category:Companies_listed_on_NASDAQ","/wiki/Category:Companies_in_the_NASDAQ_Biotechnology_Index","/w/index.php?title=Special:UserLogin&returnto=Alexion+Pharmaceuticals&type=signup","/w/index.php?title=Special:UserLogin&returnto=Alexion+Pharmaceuticals","/wiki/Alexion_Pharmaceuticals","/wiki/Talk:Alexion_Pharmaceuticals","#","/wiki/Alexion_Pharmaceuticals","/w/index.php?title=Alexion_Pharmaceuticals&action=edit","/w/index.php?title=Alexion_Pharmaceuticals&veaction=edit","/w/index.php?title=Alexion_Pharmaceuticals&action=history","#","/w/index.php","//bits.wikimedia.org/static-1.22wmf12/skins/vector/images/search-ltr.png?303-4","/wiki/Main_Page","/wiki/Main_Page","/wiki/Portal:Contents","/wiki/Portal:Featured_content","/wiki/Portal:Current_events","/wiki/Special:Random","https://donate.wikimedia.org/wiki/Special:FundraiserRedirector?utm_source=donate&utm_medium=sidebar&utm_campaign=C13_en.wikipedia.org&uselang=en","/wiki/Help:Contents","/wiki/Wikipedia:About","/wiki/Wikipedia:Community_portal","/wiki/Special:RecentChanges","//en.wikipedia.org/wiki/Wikipedia:Contact_us","/wiki/Special:WhatLinksHere/Alexion_Pharmaceuticals","/wiki/Special:RecentChangesLinked/Alexion_Pharmaceuticals","/wiki/Wikipedia:File_Upload_Wizard","/wiki/Special:SpecialPages","/w/index.php?title=Alexion_Pharmaceuticals&oldid=567523539","/w/index.php?title=Alexion_Pharmaceuticals&action=info","//www.wikidata.org/wiki/Q204727","/w/index.php?title=Special:Cite&page=Alexion_Pharmaceuticals&id=567523539","/w/index.php?title=Special:Book&bookcmd=book_creator&referer=Alexion+Pharmaceuticals","/w/index.php?title=Special:Book&bookcmd=render_article&arttitle=Alexion+Pharmaceuticals&oldid=567523539&writer=rl","/w/index.php?title=Alexion_Pharmaceuticals&printable=yes","//de.wikipedia.org/wiki/Alexion_Pharmaceuticals","//nl.wikipedia.org/wiki/Alexion_Pharmaceuticals","//pt.wikipedia.org/wiki/Alexion_Pharmaceuticals","#","//www.wikidata.org/wiki/Q204727#sitelinks-wikipedia","//en.wikipedia.org/wiki/Wikipedia:Text_of_Creative_Commons_Attribution-ShareAlike_3.0_Unported_License","//creativecommons.org/licenses/by-sa/3.0/","//wikimediafoundation.org/wiki/Terms_of_Use","//wikimediafoundation.org/wiki/Privacy_policy","//www.wikimediafoundation.org/","//wikimediafoundation.org/wiki/Privacy_policy","/wiki/Wikipedia:About","/wiki/Wikipedia:General_disclaimer","//en.wikipedia.org/wiki/Wikipedia:Contact_us","//en.m.wikipedia.org/wiki/Alexion_Pharmaceuticals","//wikimediafoundation.org/","//bits.wikimedia.org/images/wikimedia-button.png","//www.mediawiki.org/","//bits.wikimedia.org/static-1.22wmf12/skins/common/images/poweredby_mediawiki_88x31.png","//bits.wikimedia.org/en.wikipedia.org/load.php?debug=false&lang=en&modules=site&only=scripts&skin=vector&*"],"instances":[],"pdf":["http://ir.alexionpharm.com/common/download/download.cfm?companyid=ALXN&fileid=653720&filekey=54B6E214-6EAC-49F1-A94B-10BC0EC8B119&filename=2012_Annual_Report.pdf"],"categories":["Pharmaceutical companies of the United States","Companies based in Connecticut","Companies in the NASDAQ-100 Index","Companies listed on NASDAQ","Companies in the NASDAQ Biotechnology Index"],"headings":["History","References","External links"],"image":["//upload.wikimedia.org/wikipedia/en/thumb/9/9e/Alexion_Pharmaceuticals_logo.svg/275px-Alexion_Pharmaceuticals_logo.svg.png","//upload.wikimedia.org/wikipedia/commons/thumb/b/b0/Increase2.svg/11px-Increase2.svg.png","//upload.wikimedia.org/wikipedia/commons/thumb/b/b0/Increase2.svg/11px-Increase2.svg.png","//upload.wikimedia.org/wikipedia/commons/thumb/b/b0/Increase2.svg/11px-Increase2.svg.png","//upload.wikimedia.org/wikipedia/commons/thumb/b/b0/Increase2.svg/11px-Increase2.svg.png","//upload.wikimedia.org/wikipedia/commons/thumb/b/b0/Increase2.svg/11px-Increase2.svg.png","//upload.wikimedia.org/wikipedia/en/thumb/a/a4/Flag_of_the_United_States.svg/23px-Flag_of_the_United_States.svg.png","//en.wikipedia.org/w/index.php?title=Special:CentralAutoLogin/start&type=1x1&from=enwiki","//bits.wikimedia.org/static-1.22wmf12/skins/vector/images/search-ltr.png?303-4","//bits.wikimedia.org/images/wikimedia-button.png","//bits.wikimedia.org/static-1.22wmf12/skins/common/images/poweredby_mediawiki_88x31.png"],"tags":[],"members":[],"related":["Public_company","NASDAQ-100","S&P_500","Cheshire,_Connecticut","Connecticut","United_States","Chairman","Chief_Executive_Officer","Pharmaceutical_industry","Eculizumab","United_States_Dollar","Eculizumab","Hemolytic-uremic_syndrome","Paroxysmal_nocturnal_hemoglobinuria","Complement_membrane_attack_complex","EU","Cheshire,_Connecticut","Genzyme","Duke_University","Hypophosphatasia","Shiga_toxin","Hemolytic-uremic_syndrome","Food_and_Drug_Administration"]}